RHEI Pharmaceuticals, Inc. Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
12/8/2008 7:56:55 AM
More...
|
RHEI Pharmaceuticals, Inc. Elects Mrs. Zheng Hong to Board of Directors
11/20/2008 11:46:32 AM
More...
|
RHEI Pharmaceuticals, Inc. Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
8/26/2008 7:04:32 AM
More...
|
RHEI Pharmaceuticals, Inc. Licenses Attental From MethaPharma for Distribution Throughout Asia
2/19/2008 6:51:26 AM
More...
|
Access Pharmaceuticals (ACCP) Outlicenses China Rights for Mucositis Product to RHEI Pharmaceuticals, Inc.
1/14/2008 2:53:29 PM
More...
|
Access Pharmaceuticals (ACCP) Licenses MuGard(TM) to RHEI Pharmaceuticals, Inc.
1/14/2008 7:23:08 AM
More...
|
RHEI Pharmaceuticals, Inc. Appoints Timothy M. Kish President And CFO
10/11/2006 9:11:54 AM
More...
|
A.P. Pharma, Inc. (APPA) Licenses APF530 To RHEI Pharmaceuticals, Inc. For Development In Greater China
10/2/2006 12:25:50 PM
More...
|
RHEI Pharmaceuticals, Inc. Licenses Flamel Technologies (FLML)'s Asacard(R) (controlled-release aspirin) For China And Taiwan
5/4/2006 3:23:33 PM
More...
|
RHEI Pharmaceuticals, Inc. Appoints Scott Kozak Vice President Of Commercial Operations
5/1/2006 1:41:58 PM
More...
|